Overdose Prevention

This has already been addressed at DrugWarRant and The Agitator, but I'd just like to echo the observation that Dr. Bertha Madras is a cruel witch whose idea of drug prevention is willfully letting drug addicts die before our eyes.

In her capacity as Deputy Director of Demand Reduction at the Drug Czar's office, Madras is speaking out against medicines that effectively treat drug overdoses. If that sounds crazy to you, well, what can I say? These people are deranged:

...Dr. Bertha Madras, deputy director of the White House Office on National Drug Control Policy, opposes the use of Narcan in overdose-rescue programs.

"First of all, I don’t agree with giving an opioid antidote to non-medical professionals. That’s No. 1," she says. "I just don’t think that’s good public health policy."

Madras says drug users aren’t likely to be competent to deal with an overdose emergency. More importantly, she says, Narcan kits may actually encourage drug abusers to keep using heroin because they know overdosing isn’t as likely.

Madras says the rescue programs might take away the drug user’s motivation to get into detoxification and drug treatment.

"Sometimes having an overdose, being in an emergency room, having that contact with a health care professional is enough to make a person snap into the reality of the situation and snap into having someone give them services," Madras says. [NPR]

Um, maybe…if you don’t die. I seriously can’t believe my eyes. This is just as cold as it gets, even by ONDCP standards. Does she know or care that lives will be lost if her vision of good public health policy prevails? How many people should we allow to die in order to spread the message that heroin is dangerous?

This is one of those moments that reveal in stark terms the complete logical bankruptcy of the drug warrior mindset. By rejecting any interest in saving lives, Madras leaves one wondering what the hell she even wants. Seriously, what are we paying these people to do if not save lives?

This is not some crackpot narc spouting off silly soundbites in a local paper. This is a spokeswoman for the White House Office of National Drug Control Policy. These people are supposedly the smartest, most competent drug experts, charged with drafting public health policies to protect us all, and their idea of the week is to cheer from the sidelines as people die from drugs so that the rest of us will learn to behave ourselves.

ONDCP's hateful, literally fatal contempt for the people they should be helping is just so creepy and awful that one struggles to understand the continued need to expose their behavior for what it is. Really, what could I say about this organization that is not made perfectly evident by the philosophy which its own spokespeople espouse openly in our newspapers?

If I didn't know better, I'd predict that ONDCP's open opposition to preventing drug overdoses would immediately cost them what remains of their shrinking legitimacy.

For Immediate Release: June 1, 2007 Media Contact: Hilary McQuie 510-333-8554 Overdose Bill Receives Unanimous California Senate Support SACRAMENTO - California Senate Bill (SB) 767, the Overdose Treatment Liability Act, cosponsored by the Harm Reduction Coalition (HRC), a national health and human rights advocacy group working to reduce drug-related harm, the County of Los Angeles, and the Los Angeles Overdose Taskforce, passed the bipartisan California Senate yesterday in a unanimous vote. Thanks to the leadership of Senator Mark Ridley-Thomas, the author of SB 767, California legislators are beginning to recognize the importance of access to naloxone, a very safe drug that lay people, with appropriate training, can safely and properly administer. SB 767 will make it easier for health care professionals to participate in comprehensive drug overdose prevention programs that prescribe the opioid antagonist naloxone, thereby removing a large obstacle to the creation and expansion of such programs in California. This proposed legislation will also make it easier to get naloxone into the hands of the people who are the most likely to be bystanders to opioid overdoses, increasing the likelihood that people overdosing on opioids will receive naloxone promptly. When the Senate Judiciary Committee heard the bill early last month, Sandi McClure, a member of the Los Angeles Overdose Taskforce, delivered powerful testimony about the loss of her daughter, Jennifer, 15 months ago to a heroin overdose. Ms. McClure noted that if her daughter or her friends had access to naloxone and knew how to respond to an overdose, Jennifer might still be alive today. Drug overdose, which is entirely preventable, is the second leading cause of accidental death in the United States. When a person overdoses on opioids (heroin, morphine, methadone, oxycontin, etc.), he/she is rendered unconscious and is in danger of dying because the opioids slow down, and eventually stop, the person's breathing. Naloxone counteracts life-threatening depression of the central nervous and respiratory systems caused by an opioid overdose, allowing an overdose victim to breathe normally. Currently, naloxone can be prescribed only by licensed health care professionals, and has the same level of regulation as prescription ibuprofen. SB 767 protects providers who prescribe take-home naloxone, facilitating greater access to lifesaving medicine for people experiencing opioid overdoses. The Assembly Judiciary Committee will hear the bill later this month. # # # # For more information about the Harm Reduction Coalition, visit http://www.harmreduction.org/.

[Courtesy of the Harm Reduction Coalition] For Immediate Release: May 8, 2007 Contact: Emalie Huriaux, tel: 510-469-7941 Overdose Bill Moves Forward: Unanimous Judiciary Committee Support SACRAMENTO - California Senate Bill (SB) 767, the Overdose Treatment Liability Act, cosponsored by the Harm Reduction Coalition (HRC), a national health and human rights advocacy group working to reduce drug-related harm, and the County of Los Angeles passed the bipartisan California Senate Judiciary Committee today in a 5-to-0 vote. SB 767 will make it easier for health care professionals to participate in comprehensive drug overdose prevention programs that prescribe the opioid antagonist naloxone, thereby removing a large obstacle to the creation and expansion of such programs in California. This proposed legislation will also make it easier to get opioid antagonists into the hands of the people who are the most likely to be bystanders to opioid overdoses, increasing the likelihood that people overdosing on opioids will receive naloxone promptly. Emalie Huriaux, HRC's Overdose Project Manager stated after the unanimous vote, "We are pleasantly surprised. Liability legislation rarely gets support from the Senate Judiciary Committee. This vote shows that committee members understand the lifesaving effects SB 767 will have." Sandi McClure, a member of the Los Angeles Overdose Taskforce, delivered powerful testimony about the loss of her daughter, Jennifer, 15 months ago to a heroin overdose, and how access to naloxone may have saved her life. In addition, Dr. Jeffrey Gunzenhauser, Medical Director for the County of Los Angeles, spoke about the drug overdose epidemic in Los Angeles and throughout the country. Although naloxone is a very safe drug and recent studies have proven that lay people, with appropriate training, can safely and properly administer it, some clinicians are concerned about prescribing take-home naloxone for use by lay people. Clinicians voice concerns that patients may use naloxone on a third party experiencing an overdose and, in the event of an adverse reaction, the clinician could be held liable. In recent years, New York, New Mexico, and Connecticut have enacted legislation similar to SB 767 to protect licensed health care professionals from civil and criminal liability when prescribing take-home opioid antagonists. Since November 2003, HRC's Overdose Project has collaborated with the San Francisco Department of Public Health to provide overdose prevention, recognition, and response training, including naloxone prescriptions, to people at risk for experiencing an opioid overdose. To date, this collaboration has provided training and prescriptions to nearly 1,000 people and heard reports from 250 of them that they used naloxone in an overdose situation. Drug overdose, which is entirely preventable, is the second leading cause of accidental death in the United States. When a person overdoses on opioids (heroin, morphine, methadone, oxycontin, etc.), he/she is rendered unconscious and is in danger of dying because the opioids slow down, and eventually stop, the person's breathing. Naloxone counteracts life-threatening depression of the central nervous and respiratory systems caused by an opioid overdose, allowing an overdose victim to breathe normally. Currently, naloxone can be prescribed only by licensed health care professionals, and has the same level of regulation as prescription ibuprofen. SB 767 protects providers who prescribe take-home naloxone, facilitating greater access to lifesaving medicine for people experiencing opioid overdoses. The bill will be heard later this month by the Senate Appropriations Committee and, if passed, will move on for a vote by the entire Senate later this year. # # # # For more information about the Harm Reduction Coalition, visit http://www.harmreduction.org.